Lab-Grown Skin Can Grow Its Own Oil Glands, If the Cells Come From the Scalp

A paper set to appear in the September 2026 print issue of the Journal of Investigative Dermatology, already posted online since around April, reports that lab-grown skin can grow its own sebaceous glands, provided the starting cells come from the right place on the body. The team, led by Brice Magne and Lucie Germain at LOEX (Laboratoire d'Organogenese Experimentale) at Universite Laval and CHU de Quebec, built the glands inside self-assembled skin substitutes, a scaffold-free platform where cells generate their own extracellular matrix instead of being seeded onto a synthetic base.

The finding that will matter most to anyone trying to reproduce or apply it is narrower than the headline suggests: glands formed when the epithelial cells came from scalp skin, and did not form when the source was foreskin or breast skin. Fibroblast origin made no difference, which points the explanation squarely at the epithelial cells themselves rather than the surrounding tissue. That is a donor-site finding, not a universal recipe, and it sets a real constraint on translation, since scalp biopsies are not the standard donor site used today for autologous skin substitutes in burn care.

The evidence behind the claim comes from two settings: substitutes grown in vitro and substitutes grafted onto mice. What is not established in the notes available on this study, and what would need to come from the paper's own results and methods sections behind ScienceDirect's paywall, is whether the glands are shown to be functionally secretory, producing measurable sebum, or whether the evidence is histological, meaning the tissue looks like a gland under a microscope without a demonstrated output measurement. That distinction changes what the finding can support: a structural result argues for improved barrier anatomy, while a secretory result would argue for restored barrier chemistry, and grafted burn patients ultimately need the latter.

The mouse-grafting step also bounds what can be claimed. It shows the glands persist after transplantation into a living host, but mouse and human sebaceous gland biology diverge, so persistence and hormonal responsiveness in a mouse graft do not by themselves establish how the gland would behave, or for how long, in a human recipient. LOEX's broader platform has more runway than this single result: the self-assembled skin substitute is already in a human burn trial, NCT02350205, with a primary completion target around January 2028, and a gene-modified variant, GMEB-SASS, has entered trial as NCT07193134 for recessive dystrophic epidermolysis bullosa. Neither trial is testing gland-bearing grafts; both are the existing platform without this appendage.

Two other groups published different routes to the same target this year. An Advanced Materials Interfaces paper from Ryu and colleagues describes a bioprinted, structurally engineered artificial sebaceous gland built into a skin model, and a Frontiers in Toxicology paper builds sebaceous organoids directly from sebocytes embedded in a reconstructed dermal matrix. Both start from a different premise than the LOEX work: they engineer the gland's structure directly, rather than supplying epithelial cells and letting the gland self-organize. The self-organization route is closer to what happens in a decade-old proof of concept from cultured epidermal stem cells and skin-derived precursors, which reported de novo hair follicles alongside functional, lipid-excreting sebaceous glands, a result this new paper extends by identifying which donor tissue makes self-organization work at all.